Legal Representation
Attorney
Patrick J. Concannon
USPTO Deadlines
Next Deadline
180 days remaining
NOA E-Mailed - SOU Required
Due Date
January 15, 2026
Extension Available
Until July 15, 2026
Application History
12 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 15, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 22, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 22, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 22, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 22, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 22, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 7, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, nucleic acid therapeutics for use in the treatment of diseases and disorders, namely, genetic, neurologic, gastrointestinal, metabolic, immunological, cardiovascular, ocular, and oncological and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system and kidneys; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of diseases and disorders, namely, genetic, neurologic, gastrointestinal, metabolic, immunological, cardiovascular, ocular, and oncological and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system and kidneys
Class 042
Scientific research; Scientific research in the fields of pharmaceuticals and medicine; Providing scientific information in the field of pharmaceuticals and medicine; Product development for others in the field of pharmaceuticals and medicine
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RNAI"